• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau 剪接异常与 tau 病模型中的运动障碍和纹状体功能障碍相关。

Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy.

机构信息

Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), C1428ADN Buenos Aires, Argentina.

Instituto de Biología y Medicina Experimental (IBYME-CONICET), C1428ADN Buenos Aires, Argentina.

出版信息

Brain. 2021 Sep 4;144(8):2302-2309. doi: 10.1093/brain/awab130.

DOI:10.1093/brain/awab130
PMID:34059893
Abstract

Tauopathies are neurodegenerative diseases caused by the abnormal metabolism of the microtubule associated protein tau (MAPT), which is highly expressed in neurons and critically involved in microtubule dynamics. In the adult human brain, the alternative splicing of exon 10 in MAPT pre-mRNA produces equal amounts of protein isoforms with either three (3R) or four (4R) microtubule binding domains. Imbalance in the 3R:4R tau ratio is associated with primary tauopathies that develop atypical parkinsonism, such as progressive supranuclear palsy and corticobasal degeneration. Yet, the development of effective therapies for those pathologies is an unmet goal. Here we report motor coordination impairments in the htau mouse model of tauopathy which harbour abnormal 3R:4R tau isoforms content, and in contrast to TauKO mice, are unresponsive to l-DOPA. Preclinical-PET imaging, array tomography and electrophysiological analyses indicated the dorsal striatum as the candidate structure mediating such phenotypes. Indeed, local modulation of tau isoforms by RNA trans-splicing in the striata of adult htau mice, prevented motor coordination deficits and restored basal neuronal firing. Together, these results suggest that abnormal striatal tau isoform content might lead to parkinsonian-like phenotypes and demonstrate a proof of concept that modulation of tau mis-splicing is a plausible disease-modifying therapy for some primary tauopathies.

摘要

tau 病是由微管相关蛋白 tau(MAPT)的异常代谢引起的神经退行性疾病,MAPT 在神经元中高度表达,并且对微管动力学具有重要作用。在成人脑中,MAPT 前体 mRNA 中外显子 10 的选择性剪接产生具有三个(3R)或四个(4R)微管结合结构域的等量蛋白异构体。3R:4R tau 比率失衡与原发性 tau 病有关,这些疾病会发展出非典型帕金森病,如进行性核上性麻痹和皮质基底节变性。然而,开发针对这些病理的有效治疗方法仍是一个未满足的目标。在这里,我们报告了 tau 病的 htau 小鼠模型中运动协调障碍,该模型具有异常的 3R:4R tau 异构体含量,与 TauKO 小鼠不同,对 l-DOPA 无反应。临床前-PET 成像、阵列断层扫描和电生理分析表明,背侧纹状体是介导这种表型的候选结构。事实上,通过在成年 htau 小鼠纹状体中的 RNA 反式剪接来调节 tau 异构体,可以防止运动协调缺陷并恢复基底神经元放电。总之,这些结果表明,异常纹状体 tau 异构体含量可能导致类似帕金森病的表型,并证明了调节 tau 错剪接是一些原发性 tau 病可行的疾病修饰治疗方法的概念验证。

相似文献

1
Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy.tau 剪接异常与 tau 病模型中的运动障碍和纹状体功能障碍相关。
Brain. 2021 Sep 4;144(8):2302-2309. doi: 10.1093/brain/awab130.
2
SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy.tau 异构体的智能调节可挽救 tau 蛋白病临床前模型中的认知和运动障碍。
Front Bioeng Biotechnol. 2022 Oct 5;10:951384. doi: 10.3389/fbioe.2022.951384. eCollection 2022.
3
Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.tau 异构体失衡的调节可预防 tau 病小鼠模型中的 tau 病理学和认知衰退。
Cell Rep. 2018 Apr 17;23(3):709-715. doi: 10.1016/j.celrep.2018.03.079.
4
Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.新型内源性表达 3 重复和 4 重复 tau 异构体的 tau 传播小鼠模型的建立。
Brain. 2022 Mar 29;145(1):349-361. doi: 10.1093/brain/awab289.
5
The Role of Tau Proteoforms in Health and Disease.tau 蛋白异构体在健康和疾病中的作用。
Mol Neurobiol. 2023 Sep;60(9):5155-5166. doi: 10.1007/s12035-023-03387-8. Epub 2023 Jun 2.
6
Regulation of alternative splicing of tau exon 10.tau外显子10可变剪接的调控
Neurosci Bull. 2014 Apr;30(2):367-77. doi: 10.1007/s12264-013-1411-2. Epub 2014 Mar 14.
7
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.tau 相互作用蛋白:深入了解 tau 在健康和疾病中的作用。
Adv Exp Med Biol. 2019;1184:145-166. doi: 10.1007/978-981-32-9358-8_13.
8
Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.反式作用应答DNA结合蛋白43(TDP-43)调节tau外显子10的可变剪接:对tau蛋白病发病机制的影响。
J Biol Chem. 2017 Jun 23;292(25):10600-10612. doi: 10.1074/jbc.M117.783498. Epub 2017 May 9.
9
Transmission of tauopathy strains is independent of their isoform composition.tau 病株的传播与其异构体组成无关。
Nat Commun. 2020 Jan 7;11(1):7. doi: 10.1038/s41467-019-13787-x.
10
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.MicroRNA-132 的缺失与进行性核上性麻痹中 tau 外显子 10 的包含有关。
Hum Mol Genet. 2011 Oct 15;20(20):4016-24. doi: 10.1093/hmg/ddr330. Epub 2011 Aug 1.

引用本文的文献

1
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation.携带 MAPT p.K298E 突变的首个额颞叶痴呆家系的临床和神经影像学特征。
Neurogenetics. 2024 Jul;25(3):215-223. doi: 10.1007/s10048-024-00756-w. Epub 2024 Apr 9.
2
Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.利用人工 microRNAs 减少 Tau 蛋白可调节神经元生理功能,并改善小鼠 Tau 病表型。
Mol Ther. 2024 Apr 3;32(4):1080-1095. doi: 10.1016/j.ymthe.2024.01.033. Epub 2024 Feb 3.
3
Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system.
α-突触核蛋白与tau蛋白在中枢神经系统中的病理与生理功能相互作用
Neural Regen Res. 2024 Apr;19(4):855-862. doi: 10.4103/1673-5374.382231.
4
SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy.tau 异构体的智能调节可挽救 tau 蛋白病临床前模型中的认知和运动障碍。
Front Bioeng Biotechnol. 2022 Oct 5;10:951384. doi: 10.3389/fbioe.2022.951384. eCollection 2022.
5
High altitude is associated with pTau deposition, neuroinflammation, and myelin loss.高海拔与 pTau 沉积、神经炎症和髓鞘丢失有关。
Sci Rep. 2022 Apr 27;12(1):6839. doi: 10.1038/s41598-022-10881-x.
6
Tauopathies: new perspectives and challenges.tau 病:新视角与新挑战。
Mol Neurodegener. 2022 Apr 7;17(1):28. doi: 10.1186/s13024-022-00533-z.
7
Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes.进行性核上性麻痹中的抗tau蛋白策略是否需要重新考虑?答案是肯定的。
Mov Disord Clin Pract. 2021 Aug 31;8(7):1034-1037. doi: 10.1002/mdc3.13324. eCollection 2021 Oct.